BEAT THE STREET GAME:
Health Winners & Losers: Abbott
Abbott Labs climbs on new data from its Spirit III trial for its Xience V stent.
Related Topics: Winners & Losers | Health Care
03:58PM 05/13/08
Iomai Surges on $189 Million Buyout
Foreign biotech Intercell will pay $6.60 a share for Iomi.
Related Topics: Biotech | Health Care | Drugs
10:15AM 05/13/08
The biotech rises on a narrowed first-quarter loss.
Related Topics: Winners & Losers | Health Care
06:00PM 05/12/08
Cell Genesys Issues Stock in Private Placement
A single institutional investor is paying $4.22 a share for 7.1 million shares.
Related Topics: Biotech | Health Care | Drugs
10:50AM 05/12/08
Health Winners & Losers: Alnylam
Alnylam climbs on an earnigns beat.
Related Topics: Health Care | Winners & Losers
04:57PM 05/09/08
Biotech Earnings Review: Celgene, Biogen
An overview of how seven big biotech companies fared in the January-March quarter.
Related Topics: Health Care | Drugs | Biotech
03:51PM 05/09/08
Barr Pharma slides on an earnings miss.
Related Topics: Health Care | Winners & Losers
04:39PM 05/08/08
Acquisition Charges Hit Celgene
But the biotech beats Wall Street estimates on an adjusted basis, when factoring out expenses related to Pharmion.
Related Topics: Health Care | Earnings | Drugs | Biotech
10:18AM 05/08/08
Health Winners & Losers: Cephalon
Cephalon regains some ground Wednesday after a regulatory hit post-close Tuesday.
Related Topics: Winners & Losers | Health Care
04:40PM 05/07/08
Cephalon: 'Not Surprised' by FDA Panel Vote
The biotech doesn't expect financial impact in 2008 from an FDA panel's recommendation against expanded use of pain drug Fentora.
Related Topics: Stockpickr
06:57PM 05/06/08
